Shots:

• Fresenius Kabi voluntarily recalls two lots of Fluorouracil Injection with a lot number 6120341 and 6120420 to the consumer level due to the presence of glass particulate- distributed between Dec 06- 2018 & Feb 20- 2019
• Fresenius Kabi notifies its distributors and customers via letter to immediately check their stock and discontinue the utilization of affected products. The recall is being conducted under the knowledge of the US FDA
• Fluorouracil (IV) is an antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity indicated to treat multiple cancer indications

Click here to read full press release/ article | Ref: FDA | Image: Fresenius Kabi